PT  - JOURNAL ARTICLE
AU  - Corrado Campochiaro
AU  - Nicola Farina
AU  - Giacomo  De Luca
AU  - Giorgia Trignani
AU  - Alessandro Tomelleri
AU  - Marco Matucci-Cerinic
AU  - Lorenzo Dagna
TI  - Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review
AID  - 10.3899/jrheum.220213
DP  - 2022 Sep 15
TA  - The Journal of Rheumatology
PG  - jrheum.220213
4099  - http://www.jrheum.org/content/early/2022/09/11/jrheum.220213.short
4100  - http://www.jrheum.org/content/early/2022/09/11/jrheum.220213.full
AB  - Antisynthetase syndrome (AS) is a rare autoimmune disorder whose treatment remains a challenge.1 In refractory cases, treatment escalation from glucocorticoids (GCs) and immunosuppressants to rituximab (RTX) is recommended.1